Early research (Phase 1)Study completedNCT05078593
What this trial is testing
A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HLX26 Monoclonal Antibody Injection in Patients With Solid Tumor or Lymphoma
Who this might be right for
Solid Tumor, AdultLymphoma
Shanghai Henlius Biotech 18